Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15Gastrointestinal 6Other hematologic neoplasm 5Thoracic 3Head & Neck 2Classical hematology 2Sarcoma 1Other neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Precancerous Conditions 51Leukemia 13Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Neoplasms, Plasma Cell 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Acute 9Burkitt Lymphoma 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, Large-Cell, Anaplastic 8Immunoblastic Lymphadenopathy 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Biphenotypic, Acute 7Uterine Cervical Dysplasia 6Primary Myelofibrosis 6Leukemia, Prolymphocytic 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pathologic Complete Response × Other neoplasm × Clear all
NCT05103293 2023-12-27

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Completed
86 enrolled
BreastOther neoplasm

Pathologic Complete Response, Breast Neoplasms, Pathological Conditions, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡